statistiche ricercatore

Nome	#
Deletions of Chromosome 7q Affect Nuclear Organization and HLXB9Gene Expression in Hematological Disorders	62
Gene nuclear positioning in leukaemia with chromosome 7 rearrangements	54
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma	51
Nuclear Repositioning of the Non-Translocated HLXB9 Allele in the Leukaemia Cell Line GDM-1 Harbouring a t(6;7)(q23;q36)	47
Secondary metabolic profiles and anticancer actions from fruit extracts of immature pomegranates	30
NLC for the delivery of new prodrugs in the treatment of uveal melanoma	5
Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma	5
Haloperidol metabolite II Valproate ester-loaded NLC as promising strategy for the treatment of Uveal Melanoma	4
NLC as promising platform to deliver new prodrugs in the treatment of ophthalmic cancer	3
Localizzazione intranucleare ed espressione del gene HLXB9 nel differenziamento neuronale in vitro e nell insorgenza di disordini mielodi	2
Totale	263

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	4	0	0	0	0	0	0	0	0	0	0	4	0
2019/2020	28	8	2	1	1	2	3	5	0	1	0	3	2
2020/2021	18	0	0	2	0	3	1	2	0	0	0	6	4
2021/2022	43	2	5	0	2	5	1	9	3	3	3	0	10
2022/2023	108	10	11	0	14	8	13	0	27	18	0	5	2
2023/2024	47	2	11	0	9	1	17	0	4	1	2	0	0
Totale													263